Killing of Normal Melanocytes, Combined with Heat Shock Protein 70 and CD40L Expression, Cures Large Established Melanomas

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.177.6.4168PMID 16951382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of autoimmunity during treatment of melanoma with interferon.

  2006cited by this paper
• Autoimmunity and immunotherapy for cancer.

  2006cited by this paper
• Autoimmunity and tumor immunity induced by immune responses to mutations in self

  2006cited by this paper
• Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.

  2005cited by this paper
• Immunotherapy dispenses with tumor antigens

  2004cited by this paper
• Heat shock proteins transfer peptides during antigen processing and CTL priming

  2004cited by this paper
• HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation.

  2004cited by this paper
• Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity

  2004cited by this paper
• A simple method to cure established tumors by inflammatory killing of normal cells

  2004cited by this paper
• Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN

  2004cited by this paper
• Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo

  2003influential reference
• Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells

  2003cited by this paper
• Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells.

  2003cited by this paper
• Hypothesis: controlled necrosis as a tool for immunotherapy of human cancer.

  2003cited by this paper
• Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

  2003cited by this paper
• Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

  2003cited by this paper
• Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

  2003cited by this paper
• Determinant spreading and tumor responses after peptide-based cancer immunotherapy.

  2003cited by this paper
• Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

  2003cited by this paper
• Analysis of Survival Times

  2003cited by this paper
• Vaccines: Spinning molecular immunology into successful immunotherapy

  2002cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• The enemy within: keeping self-reactive T cells at bay in the periphery

  2002cited by this paper
• CD40, an extracellular receptor for binding and uptake of Hsp70–peptide complexes

  2002cited by this paper
• Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

  2002cited by this paper
• A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory

  2002cited by this paper
• Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

  2002cited by this paper
• Novel Signal Transduction Pathway Utilized by Extracellular HSP70

  2002cited by this paper
• Cross-presentation in viral immunity and self-tolerance

  2001cited by this paper
• Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.

  2001cited by this paper
• A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.

  2001cited by this paper
• Interleukin-6 promoter polymorphism (--174 G/C) in Caucasian German patients with systemic lupus erythematosus.

  2001cited by this paper
• Macrophages orchestrate the immune response to tumor cell death.

  2001cited by this paper
• Soluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells1

  2000cited by this paper
• Receptor-Mediated Uptake of Antigen/Heat Shock Protein Complexes Results in Major Histocompatibility Complex Class I Antigen Presentation via Two Distinct Processing Pathways

  2000cited by this paper
• Cross-Presentation of Glycoprotein 96–Associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-Mediated Endocytosis

  2000cited by this paper
• Isolation of Mouse Mononuclear Cells

  2000cited by this paper
• Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo.

  2000cited by this paper
• Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70.

  2000cited by this paper
• HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine

  2000cited by this paper
• Tyrosinase Family Proteins Are Antigens Specific to Vogt-Koyanagi-Harada Disease1

  2000cited by this paper
• Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40

  1999cited by this paper
• CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

  1999cited by this paper
• Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

  1999cited by this paper
• Inducing autoimmune disease to treat cancer.

  1999cited by this paper
• Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

  1998cited by this paper
• T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

  1998cited by this paper
• Help for cytotoxic-T-cell responses is mediated by CD40 signalling

  1998cited by this paper
• Heteroclitic Immunization Induces Tumor Immunity

  1998cited by this paper
• A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

  1998cited by this paper
• Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.

  1998cited by this paper
• Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.

  1997cited by this paper
• Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations.

  1997cited by this paper
• Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

  1997cited by this paper
• In vivo gene therapy of malignant tumours with heat shock protein-65 gene

  1997cited by this paper
• Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24.

  1996cited by this paper
• T cell receptor antagonist peptides induce positive selection.

  1994influential reference
• A cell‐specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number‐related expression in transgenic mice.

  1994cited by this paper
• CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

  1994cited by this paper
• Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

  1994cited by this paper
• Humoral immune responses in CD40 ligand-deficient mice

  1994cited by this paper
• Drug sensitivity ("suicide") genes for selective cancer chemotherapy.

  1994cited by this paper
• Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors

  1993cited by this paper
• Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells.

  1993cited by this paper
• Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.

  1993cited by this paper
• In vitro and in vivo targeting of gene expression to melanoma cells.

  1993cited by this paper
• Current protocols in immunology

  1991cited by this paper
• Practical statistics for medical research

  1990cited by this paper

• New progress in the treatment of diffuse midline glioma with H3K27M alteration

  2024cites this paper
• HSP90 Complex From OLP Lesion Induces T-Cell Polarization via Activation of Dendritic Cells.

  2024cites this paper
• Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors

  2020cites this paper
• Defending against pathogens-immunological priming and its molecular basis in a sea anemone , cnidarian

  2019cites this paper
• Chaperones

  2018cites this paper
• Hsp70: A Cancer Target Inside and Outside the Cell.

  2018cites this paper
• Phenomenological and Molecular Basis of the Cnidarian Immune System

  2017influential citation
• Manipulation of Innate and Adaptive Immunity through Cancer Vaccines

  2017cites this paper
• Targeting Hsp70: A possible therapy for cancer.

  2016cites this paper
• Skin cancer and new treatment perspectives: a review.

  2015cites this paper
• Defending against pathogens – immunological priming and its molecular basis in a sea anemone, cnidarian

  2015cites this paper
• Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.

  2014cites this paper
• Interferon-γ Induces Senescence in Normal Human Melanocytes

  2014cites this paper
• A central role for inducible heat‐shock protein 70 in autoimmune vitiligo

  2013cites this paper
• The association between heat shock protein P2/P2 genotype with Egyptian hepatocellular carcinoma patients

  2013influential citation
• The Complex Function of Hsp70 in Metastatic Cancer

  2013cites this paper
• Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

  2013cites this paper
• Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers

  2013cites this paper
• Hypoxia‐induced response of cell cycle and apoptosis regulators in melanoma

  2012cites this paper
• Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity

  2012influential citation
• Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity.

  2012cites this paper
• Subcutaneous phaeohyphomycosis in immunocompetent child caused by Exophiala jeanselmei

  2012cites this paper
• HSP70i is a critical component of the immune response leading to vitiligo

  2012cites this paper
• Viral antigen mediated NKp46 activation of NK cells results in tumor rejection via NK-DC crosstalk

  2012cites this paper
• Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma

  2012cites this paper
• Chemoprevention of Familial Melanoma

  2011cites this paper
• Molecular Chaperones

  2011cites this paper
• Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment

  2011cites this paper
• Hsp70: anti-apoptotic and tumorigenic protein.

  2011cites this paper
• Broad Antigenic Coverage Induced by Viral cDNA Library-based Vaccination Cures Established Tumors

  2011cites this paper
• Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come

  2011cites this paper
• Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma.

  2011cites this paper
• Improving Polymer-Mediated DNA Vaccine Delivery

  2011cites this paper
• Hsp70 and Hsp27: Emerging Targets in Cancer Therapy

  2010cites this paper
• Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma

  2010cites this paper
• Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus

  2010influential citation
• Immune/Inflammatory Aspects

  2010cites this paper
• Adenoviral vaccination combined with CD40 stimulation and CTLA-4 blockage can lead to complete tumor regression in a murine melanoma model.

  2010cites this paper
• Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.

  2009cites this paper
• Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas.

  2009cites this paper
• HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo.

  2008cites this paper
• Heat Shock Protein A1B 1267 Polymorphism Is Highly Associated With Risk and Prognosis of Hepatocellular Carcinoma: A Case-Control Study

  2008cites this paper
• Heat Shock Protein A1B 1267 Polymorphism Is Highly Associated With Risk and Prognosis of Hepatocellular Carcinoma

  2008cites this paper
• Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

  2008cites this paper
• Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins.

  2007cites this paper
• Adenovirus-mediated CD40 ligand immunotherapy of prostate and bladder cancer.

  2007cites this paper
• Adenovirus-mediated CD 40 Ligand Immunotherapy of Prostate and Bladder Cancer

  2007cites this paper
• Secreting Heat Shock Protein 70 Cancer Immunotherapy Using Irradiated Tumor Cells

  2007cites this paper
• Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer.

  2007cites this paper
• Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.

  2007cites this paper
• Send Orders of Reprints at Reprints@benthamscience.org Lysosomal Rerouting of Hsp70 Trafficking as a Potential Immune Activating Tool for Targeting Melanoma

  year unknowncites this paper